Clinical trial
Montelukast in Very Low Birthweight Infants
NCT00492102 · Children's Hospital Medical Center, Cincinnati, Other · Completed
Key facts
| NCT number | NCT00492102 |
|---|---|
| Title | Montelukast in Very Low Birthweight Infants |
| Official title | Pharmacokinetics of Montelukast in Very Low Birthweight (VLBW) Preterm Infants |
| Lead sponsor | Children's Hospital Medical Center, Cincinnati, Other |
| Collaborators | Merck Sharp & Dohme LLC Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Bronchopulmonary Dysplasia |
| Intervention type | Drug |
| Interventions | Montelukast |
| Enrollment | 9 |
| Start date | Mar 1, 2007 |
| Primary completion | Jun 1, 2011 |
| Completion | Jun 1, 2011 |
| First posted | Jun 27, 2007 |
| Last update posted | Aug 2, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: